Klarquist News & Insights

Federal Circuit IP

Inline Plastics Corp. v. Lacerta Group, LLC

Fed. Cir. 2022-1954, 2022-2295 March 27, 2024 (Taranto, Chen, Hughes; Precedential) Summary: The Federal Circuit vacates the District Court for the District of Massachusetts’s judgment in favor of Lacerta because the district court gave incorrect jury instructions, which did not mention several objective indica of nonobviousness for which there was evidence. Background In 2018, Inline […]

Read More

Federal Circuit IP

Harris Brumfield, Trustee for Ascent Trust v. IBG LLC, Interactive Brokers LLC

Fed. Cir. 2022-1630 Mar. 27, 2024 (Prost, Taranto, Hughes; Precedential) Summary: The Federal Circuit affirmed the District Court for the Northern District of Illinois and found that (1) patent owners may be able to recover damages for foreign sales if a domestic act of infringement under § 271(a) is the proximate cause of the foreign […]

Read More

Federal Circuit IP

Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. Ltd.

Fed. Cir. 2022-1877 March 25, 2024 (Lourie, Stoll, Cunningham; Precedential) Summary: The Federal Circuit affirmed the District Court for the Northern District of California and found that the FDA safe harbor under § 271(e)(1) applied to Meril’s importation of two Myval prosthetic heart valve systems. Background In 2019, Meril imported two Myval prosthetic heart valve […]

Read More

Federal Circuit IP

Rai Strategic Holdings, Inc. v. Philip Morris Products S.A.

Summary: The Federal Circuit overturns the PTAB to find written description for a percentage range for the length of a heating element in the context of an electro-mechanical smoking device. Background Appellant-Patent Owner (Rai Strategic) appeals a PRG filed by Appellee-Petitioner (Philip Morris), which found that the challenged U.S. Patent No. 10,492,542 (“the ’542 patent”) […]

Read More

Federal Circuit IP

Penumbra, Inc. v. RapidPulse, Inc.

PTAB IPR2021-1446 March 10, 2023; Designated Precedential November 15, 2023 (Melvin, Cotta, Wisz; PTAB Precedential) Summary: Precedential PTAB opinion details the test for a patent or published application to obtain the effective filing date of a claimed provisional under AIA Section 102(d). Background Petitioner (Penumbra) filed an IPR challenging U.S. Patent No. 10,531,883 (“the ’883 […]

Read More

Federal Circuit IP

Weber, Inc. v. Provisur Technologies, Inc.

Federal Circuit 2022-1751, 2022-1813 February 8, 2024 (Reyna, Hughes, Stark; Precedential) Summary: The Federal Circuit overturns the PTAB to find that despite limited distribution and copyright restrictions, Petitioner’s operating manuals are publicly accessible printed publications. Background Appellate-Petitioner (Weber) filed IPR petitions on two patents (U.S. Patent Nos. 10,639,812 & 10,625,439) related to high-speed mechanical slicers […]

Read More

Federal Circuit IP

Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc.

CAFC Opinion No. 2022-1482, Decided November 21, 2023 (Dyk, Hughes, Stoll) (Precedential) Overview: Matter of first impression: PTAB can issue final written decisions after the statutory deadline. Facts/Procedural Posture: Board institutes PGR of asserted Purdue patent. Roughly six months later, Purdue files for bankruptcy and imposition of an automatic stay. PTAB stays the PGR proceeding. […]

Read More

Federal Circuit IP

H. Lundbeck A/S v. Lupin Ltd.

CAFC Opinion No. 2022-1194, Decided December 7, 2023 (Dyk, Prost, Hughes) (Precedential) Overview: No infringement of narrow method-of-use pharma patent where generic drug is labeled for a broad/general use claimed in an expired patent. Facts/Procedural Posture: Lundbeck initially obtains patents on using drug to treat depression (the broader patents) Then, after finding that the drug […]

Read More

Federal Circuit IP

VLSI Tech. LLC v. Intel Corp.

CAFC Opinion No. 2022-1906, Decided December 4, 2023 (Lourie, Dyk, Taranto) (Precedential) Overview: $2.2 billion jury verdict overturned: jury’s infringement finding reversed for one of the two asserted patents, jury’s damage award vacated and remanded for the other asserted patent. Facts/Procedural Posture: VLSI (an NPE) sues Intel in W.D. Texas for infringing two patents: the […]

Read More

Federal Circuit IP

Axonics, Inc. v. Medtronic, Inc.

CAFC Opinion No. 2022-1532-1533, Decided August 7, 2023 (Lourie, Dyk, Taranto) (Precedential) Overview: Petitioner in IPR must be given an opportunity to respond to new construction raised in the Patent Owner Response (POR). Facts/Procedural Posture: Medtronic, Inc. owns the ’758 and ’148 patents which are directed to the transcutaneous charging of implanted medical devices. Axonics […]

Read More